China Moves to Ban 12 Solar Technologies From Export Abroad

China began requiring exporters to register specified solar-manufacturing technology transfers with its commerce ministry on Friday, 16 October 2026, while a draft rule proposes banning or restricting 12 photovoltaic technologies outright. The interim registration is already live. The final shape of these China solar export controls is not, with public consultation open until 15 November 2026.

The stakes fall on anyone building solar factories outside China. Most of them rely on Chinese production lines, process know-how and equipment to do it.

The solar entries sit inside a wider 40-technology revision that also covers artificial intelligence and biomedicine. Here is which technologies are hit, which countries and companies carry the most exposure, and which signals matter before the consultation closes.

Who is exposed when the equipment and know-how stop flowing?

Picture a new cell factory in Texas or Gujarat. The machines can arrive on schedule and the line still fails to run at competitive yields, because the process recipes, control software and Chinese engineers who tune the tools never come with them.

That is where the proposal bites. It targets technology transfers and equipment-making know-how, not finished panels.

The US and Tesla

Reuters reported on 20 March 2026 that Tesla was discussing the purchase of about US$2.9 billion of Chinese solar-panel and cell-manufacturing equipment, including from Suzhou Maxwell Technologies. Some of that equipment reportedly needed approval from China’s commerce ministry.

On 15 April 2026, Reuters cited five people familiar with the matter as saying Chinese officials had held early talks with equipment makers about limiting the most advanced exports to the US. The talks reportedly focused on high-end equipment for heterojunction (HJT) cells. No rule had been finalised at that point.

Reuters’ assessment: Export restrictions could threaten plans by Tesla and other US companies to build or expand domestic solar manufacturing.

No authoritative aggregate figure exists for US dependence on Chinese PV equipment. The exposure is transaction-specific.

The Tesla equipment talks illustrate a wider pattern in which US solar manufacturing supply chains remain tied to Chinese tools, process know-how and commissioning support, so any approval requirement can delay domestic capacity plans regardless of purchase orders.

India’s cell gap

India’s position is more structural. Chinese cells made up about 90% of India’s cell imports in FY2024-25, up from 70%, and imports from China rose 141% to 4.55 billion cells, according to the HKUST Global Supply Chain Report.

On 23 July 2026, Reuters reported that Indian industry sources blamed Chinese curbs on equipment sales for delayed or idled factories trying to move from module assembly into cell production.

If you are building or financing cell capacity outside China, the risk sits in commissioning and yield, not the purchase order. Schedule and cost assumptions are what to stress-test.

Which 12 technologies are covered, and what is banned versus restricted?

The draft is Joint Announcement No. 48 of 2026, issued by the Ministry of Commerce (MOFCOM) and the Ministry of Science and Technology. Its 40 additions split into 23 AI, 12 PV and 5 biomedicine technologies.

The reported bans target the newest technologies. Perovskite is a newer solar material with the potential to convert sunlight more efficiently than silicon does. Tandem cells layer perovskite over silicon so that more of the solar spectrum is captured. Fluidized-bed polysilicon is a manufacturing route that costs less and uses less energy than the dominant Siemens process.

Category assignments reflect the most consistent public reporting; the 12 entries have not been published individually by category.

For you, the split means perovskite and tandem technologies are the ones foreign manufacturers are least likely to obtain. Mainstream high-efficiency lines face a permission regime rather than a wall.

Why is Beijing doing this, and does it add up?

The official case is security.

Ministry rationale: The revision aims to stop core technologies leaking abroad, with PV increasingly used in aerospace and national defence, while still permitting normal international scientific exchange.

Analysts quoted by the Global Times added that China now exports advanced technology as well as importing it, so the catalogue needs updating. Reuters and Bloomberg read a competitive motive too: protecting China’s lead as the US and India localise production.

That lead is large. The International Energy Agency (IEA) put China’s share above 80% across every key PV manufacturing stage in December 2024, with wafer capacity at about 95% and its prospective polysilicon, ingot and wafer share near 95% on capacity under construction. Other series measure production by year and give slightly different numbers; the methods differ, the conclusion does not.

The move also extends a pattern from raw materials to manufacturing know-how:

• December 2023: ban on rare-earth magnet manufacturing technology
• 2023-24: controls on gallium, germanium and other critical minerals
• January 2025: controls on lithium-processing technologies

The counterweight is overcapacity. Chinese equipment makers have every reason to keep selling abroad, so tight controls carry a commercial cost at home.

This is better read as a standing policy tool China is extending across industries than as a one-off solar dispute. Your exposure should be assessed as ongoing.

China’s earlier rare earth export controls followed the same logic of moving from raw materials to processing and manufacturing know-how, which is why analysts treat the solar catalogue as part of a standing policy toolkit.

What to watch before 15 November and beyond

The draft is not final. The catalogue could narrow definitions, shift thresholds or soften controls, though interim registration applies regardless.

Enforcement is hard because know-how travels through engineers, joint ventures and software. Third-country subsidiaries and older equipment offer workarounds, while forced diversification raises near-term costs but erodes China’s leverage over time.

Wood Mackenzie reported on 20 July 2026 that solar PV imports fell about 50% year-on-year in Q1 2026 amid trade actions, supporting a structural fragmentation reading. Reuters has also reported that Chinese manufacturers do not expect demand alone to clear overcapacity, and the IEA argues that concentration itself justifies diversification.

Based on precedent, the likelier outcome appears to be selective, administratively managed restriction rather than a total shutdown. That is an assessment, not a forecast. Conventional crystalline silicon dominates installed capacity, so the immediate deployment effect may be limited; advanced lines and perovskite processes carry the sharpest impact.

Watch these five signals:

1. Final catalogue wording and thresholds
2. How MOFCOM processes interim registrations
3. Any US or Indian policy response
4. Export disclosures from Chinese equipment makers
5. Evidence of non-Chinese equipment supply scaling

The next four weeks are an information window. Definitions and thresholds in the final text will matter more to your exposure than the headline count of 12.

These statements are speculative and subject to change based on regulatory and market developments.

Readers interested in how licensing regimes work in practice can use our comprehensive walkthrough of China’s rare earth export licensing, which explains how the January 2025 requirements operate.

Reading the draft as a decision point, not a verdict

The proposal is real and already partly in force through registration, but its final scope is unsettled. The exposure is concentrated in advanced cell lines and next-generation technology, with Indian and US projects most reliant on Chinese equipment and process know-how.

The consultation closes on 15 November, and the final catalogue will show whether Beijing builds a hard barrier or a licensing gate. That text, not the draft, is the point at which project timelines and cost assumptions should be re-run.

This article is for informational purposes only and should not be considered financial advice. Investors should conduct their own research and consult with financial professionals before making investment decisions.

—